Understanding & Control of Material Process Variance in Generic Drug Manufacturer (Q233375): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in 1 language: Changing unique label-description pair)
(‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Property / financed by
 
Property / financed by: Directorate-General for Regional and Urban Policy / rank
Normal rank
 

Revision as of 00:55, 30 October 2020

Project Q233375 in Ireland
Language Label Description Also known as
English
Understanding & Control of Material Process Variance in Generic Drug Manufacturer
Project Q233375 in Ireland

    Statements

    0 references
    102,773.69 Euro
    0 references
    205,547.38 Euro
    0 references
    50.0 percent
    0 references
    1 March 2015
    0 references
    20 August 2017
    0 references
    University of Limerick
    0 references
    Understanding & Control of Material Process Variance in Generic Drug Manufacturer (English)
    0 references

    Identifiers

    305
    0 references